ADMA Biologics Inc is trading 10% up at $8.80 in pre-market, extending a multi-day uptrend that started in late May.
- The move appears driven by momentum and speculative interest, with traders focusing on prior bullish sentiment rather than new fundamental developments.
- There are no fresh company-specific headlines, earnings, FDA decisions, or major analyst calls reported this morning.